期刊文献+

耐环丙沙星患病动物源沙门菌的多重耐药分子特征 被引量:1

Molecular characterization of ciprofloxacin-resistant Salmonella isolates from sick animals
原文传递
导出
摘要 采用13株耐环丙沙星食品动物源沙门菌进行喹诺酮类作用靶位基因及质粒介导耐药基因的扩增测序、有机溶剂耐受试验、HeLa细胞侵袭试验,探讨其多重耐药的分子特征。结果显示,菌株均携带质粒介导的喹诺酮耐药基因,7株对环丙沙星敏感性降低或低水平耐药(最小抑菌浓度0.125~4μg/mL),靶位基因无突变或gyrA单位点突变及外排泵活性增强;5株对环丙沙星高水平耐药(最小抑菌浓度32~128μg/mL),均在gyrA和parC发生双位点突变及外排泵活性增强,其中4株携带β内酰胺酶blaCTX-M基因。对环丙沙星高水平耐药的沙门菌的侵袭力显著高于敏感菌株。表明患病食品动物源沙门菌中,无论外排能力增强与否,gyrA单位点突变或质粒介导的喹诺酮耐药基因阳性,仅导致沙门菌对环丙沙星的低水平耐药;而外排泵机制联同染色体靶位基因突变可导致菌株对环丙沙星的高水平耐药,往往同时携带blaCTX-M基因;临床分离沙门菌随着对环丙沙星耐药程度的增加侵袭力增强。 A total of 13 non-duplicate Salmonella isolates resistant to ciprofloxacin were collected from sick food-producing animals subjected to phenotypic characterization including the amplification of plasmid- mediated quinolone resistance(PMQR) genes,as well as fl-lactamases encoding genes only in PMQR posi- tive isolates by PCR, the screening of mutations in the quinolone resistance-determining regions of gyrA and parC by PCR. The qnr,aac(6′)-Ib-cr and oqxA genes were detected in 13 of the isolates and were fre- quently co-prevalent. Seven isolates demonstrated reducing susceptible or low resistant for ciprofloxacin with minimal inhibitory concentration(MIC) from 0. 125 to 4μg/mL. These isolates had either single muta- tion in gyrA or no mutation in any target genes as well the active efflux. Five isolates except one presented double mutations in both gyrA and parC and the active efflux conferring high resistant level to ciprofloxa- cin(MIC,32--128μg/mL). Only blacTx-M type ESBLs were detected in 4 isolates with PMQR presenting high level of resistance to ciprofloxacin. Reduced ciprofloxacin susceptibility was arisen from either single mutation in gyrA or the presence of PMQR genes,irrelevant to the active efflux,while high level of resis- tance to ciprofloxacin was conferred by chromosomal mutations in target genes combining with active efflux.
出处 《中国兽医科学》 CAS CSCD 北大核心 2012年第7期747-752,共6页 Chinese Veterinary Science
基金 国家自然科学基金资助项目(30871890) 国家自然科学基金-广东省自然科学基金联合基金重点项目(U0631006)
关键词 沙门菌 质粒介导的喹诺酮耐药 多重传播 Salmonella plasmid-mediated quinolone resistance(PMQR) co-prevalence
  • 相关文献

参考文献34

  • 1HOHMANN E L. Nontyphoidal salmonellosis[J]. Clin Infect Dis, 2001,32(2) : 263-269.
  • 2HAKANEN A, KOTILAINEN P, HUOVINEN P, et al. Re- duced fluoroquinolone susceptibility in Salmonella enterica se- rotypes in travelers returning from Southeast Asia[J]. Emerg Infect Dis,2001,7(6):996 1003.
  • 3JEAN S, HSUEH R. High burden of antimicrobial resistance in Asia[J]. Int J Antimicrob Agents ,2011,37(4) :291-295.
  • 4BIEDENBACHA D J, TOLEMAN M, WALSH T R, et al. Analysis of Salmonella spp. with resistance to extended-spec trum cephalosporins and fluoroquinolones isolated in NorthAmerica and Latin America:report from the SENTRY Antimi- crobial Surveillance Program( 1997- 2004)[J]. Diagn Micro- biol Infect Dis, 2006,54 (1) : 13-21.
  • 5MOLBAK K, GERNER S, WEGENER H C. Increasing qui- nolone resistance in Salmonella enterica serotype Enteritidis [J]. Emerg Infect Dis,2002,8(5) :514-515.
  • 6YANG B, QU D, ZHANG X, et al. Prevalence and charac- terization of Salmonella serovars in retail meats of marketplace in Shanxi,China[J]. Int J Food Microbiol, 2011,141 (1/2) : 63-72.
  • 7GRAHAM S M. Nontyphoidal salmonellosis in Africa[J]. Curt Opin Infect Dis ,2010,23(5):409-414.
  • 8JACOBY G A. Mechanisms of resistance to quinolones[J]. Clin Infect Dis ,2005,41(Suppl. 2) : 120-126.
  • 9STRAHILEVITZ J, GEORGE A, DAVID C, et al. Plasmid- mediated cluinolone resistance: a multifaceted threat [J].Clin Microbio! Rev, 2009,22(4) : 664-689.
  • 10NORDMANN P,POIREL L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae[J].J Antimi crob Chemother, 2005,56 (3) ; 463-469.

二级参考文献12

  • 1陈金顶,索青利,廖明,辛朝安.沙门氏菌的invA基因序列分析与分子检测[J].中国人兽共患病杂志,2004,20(10):868-871. 被引量:58
  • 2马孟根,王红宁,余勇,李成忠,张东,羊云飞,刘世贵.猪源致病性沙门氏菌耐药基因的分析[J].畜牧兽医学报,2006,37(1):65-70. 被引量:65
  • 3王晓泉,焦新安,刘晓文,陈祥,宦海霞,刘秀梵.江苏部分地区食源性和人源沙门氏菌的多重耐药性研究[J].微生物学报,2007,47(2):221-227. 被引量:89
  • 4STRAHILEVITZ J, JACOBY G A, HOOPER D C, et al. Plasmid-mediated quinolone resistance: a multifaceted threat [ J ]. Clinical Microbiology Reviews, 2009,22 ( 4 ) : 664-689.
  • 5SORENSEN A H, HANSEN L H, JOHANNESEN E, et al. Conjugative plasmid conferring resistance to olaquindox [ J]. Antimicrob Agent Chemother,2003,47: 798-799.
  • 6NORMAN A, HANSEN L H, SHE Qun-xin, et al. Nucleo- tide sequence of pOLA52 A conjugative IncX1 plasmid from Escherichia coli which enable biofilm formation and multidrug efflux [ J ]. Plasmid ,2008,60 ( 1 ) : 59-74.
  • 7HANSEN L H,SORENSEN S J,JORGENSEN H S,et al. The prevalence of the OqxAB muhigrug efflux pump a- mongst olaquindox-resistant Escherichia coli in pigs [ J ]. Microb Drug Resist,2005,11 : 378-382.
  • 8KIM H B, WANG Ming-hua, PARK C H, et al. oqxAB en- conding a muhidrug efflux pump in human clinical isolate of Enterbacteriaceae [ J ]. Antimicrobial Agents and Chem- otherapy ,2009,53 ( 8 ) : 3528-3584.
  • 9HANSEN L H,JENSEN L B, SORENSEN H I, el al. Sub- strate specificity of the OqxAB multidrug resistance pump in Escherichia coil and selected enteric bacteria [ J ]. Jour- nal of Antimicrobial Chemotherapy, 2007,60 ( 1 ) : 145- 147.
  • 10HANSEN L H, JOHANNESE E, BURMOLLE M, et al. Plasmid-encode muhidrug efflux pump conferring resisi- tance to olaquindox in Escherichia coil[ J ]. Antimicrobial Agents and Chemotherapy,2004,48 (9) : 3332-3337.

共引文献5

同被引文献18

  • 1崔俊昌,刘又宁,王睿,梁蓓蓓,裴斐,郑专杰.4种氟喹诺酮类药物对金黄色葡萄球菌的防耐药变异浓度[J].中华医学杂志,2004,84(22):1863-1866. 被引量:34
  • 2崔俊昌,刘又宁,王睿,梁蓓蓓.氟喹诺酮药物对金黄色葡萄球菌同源耐药突变株的耐药突变选择窗研究[J].中国抗生素杂志,2006,31(4):212-215. 被引量:11
  • 3李国涛,鲁猛厚.氟喹诺酮类药物对伤寒沙门菌的防突变浓度测定[J].中华传染病杂志,2007,25(5):276-278. 被引量:4
  • 4Zhao X, Drlica K. Restricting the selection of antibiotic-resist ant mutants: a general strategy derived from fluoroquinolonc studies[J]. Clin Infect Dis, 2001, 33 (Suppl3) : 147-156.
  • 5Drlica K, Zhao X. Mutant selection window hypothesis upda- ted[J]. Clin Infect Dis, 2007, 44(5): 681-688.
  • 6Liang B, Bai N, Cai Y, et al. Mutant prevention concentra- tion-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus [J]. Antimicrob A- gents Chemother, 2011, 55(5): 2409-2412.
  • 7Cai Y, Yang J, Kan Q, et al. Mutant prevention concentra- tion of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter bauman- nii[J]. Int J Antimierob Agents, 2012, 40(5) : 477-478.
  • 8Allen G P, Deshpande L M. Determination of the mutant se- lection window for elindamycin, doxycycline, linezolid, moxi- floxacin and trimethoprim/sulfamethoxazole against communi- ty-associate[J]. Int J Antimicrob Agents, 2010, 35(1): 45- 49.
  • 9Allen G P, Hankins C D. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae [J]. J Antimicrob Chemother, 2009, 64(2): 359-363.
  • 10Sano C, Tatano Y, Shimizu T, et al. Comparative in vitro and in vivo antimierobial activities of sitafloxaein, gatifloxacin and moxi[loxacin againstMycobacteriumavium[J]. IntJ An- timierob Agents,2011, 37(4) : 296-301.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部